undefined

About Us
Professional modernized biopharmaceutical enterprise
Liaoning Boao Biopharmaceutical Co., Ltd. was founded in 2010, located in Benxi Economic and Technological Development Zone, National Liaoning (Benxi) Biomedical Industry Base, is a modernized biopharmaceutical enterprise integrating R&D and production of insulin series products. Covering an area of 35,000 square meters and a building area of 20,000 square meters, it has fixed assets of nearly 200 million yuan. Liaoning Boao Bio-pharmaceutical Co., Ltd. always takes human health as its purpose, and takes serving the society and returning the society as its responsibility. We strive to take an innovative path in the field of biopharmaceuticals. Under the premise of constantly introducing high-tech talents, it has developed the world's leading recombinant protein drug recombinant human insulin, as well as its long-acting analog Glycine Insulin and fast-acting analog Menthol Insulin. Relying on the policy advantages, regional advantages, as well as the existing talents and scientific and technological advantages, Liaoning Boao Bio-pharmaceutical Co., Ltd. has made the enterprise gradually develop into a modernized pharmaceutical enterprise with intensive technology, standardized management, excellent products and reliable quality in a short period of time.
Reasons for choosing Boao
Authoritative brand in the industry A trusted partner

undefined

BOAO Products
Saccharin
Injection and API
Glargine insulin injection and
activepharmaceutical ingredients
Specification:3ml:300 units/ink/pre-filled
Indications:diabetes need insulin therapy